[HTML][HTML] Emerging albumin-binding anticancer drugs for tumor-targeted drug delivery: current understandings and clinical translation

H Cho, SI Jeon, CH Ahn, MK Shim, K Kim - Pharmaceutics, 2022 - mdpi.com
Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

H Cho, SI Jeon, CH Ahn, MK Shim, K Kim - Pharmaceutics, 2022 - pure.ewha.ac.kr
Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation.

H Cho, SI Jeon, CH Ahn, MK Shim, K Kim - Pharmaceutics, 2022 - europepmc.org
Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation.

H Cho, SI Jeon, CH Ahn, MK Shim, K Kim - Pharmaceutics, 2022 - search.ebscohost.com
Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

H Cho, SI Jeon, CH Ahn, MK Shim, K Kim - Pharmaceutics, 2022 - pure.korea.ac.kr
Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

H Cho, SI Jeon, CH Ahn, MK Shim, K Kim - Pharmaceutics, 2022 - s-space.snu.ac.kr
Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

H Cho, SI Jeon, CH Ahn, MK Shim… - Pharmaceutics, 2022 - pubmed.ncbi.nlm.nih.gov
Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

[HTML][HTML] Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

H Cho, SI Jeon, CH Ahn, MK Shim, K Kim - Pharmaceutics, 2022 - ncbi.nlm.nih.gov
Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

H Cho, SI Jeon, CH Ahn, MK Shim, K Kim - Pharmaceutics, 2022 - search.proquest.com
Albumin has shown remarkable promise as a natural drug carrier by improving
pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The …